OFFICIAL PUBLICATION OF

by its subsidiary APPco

PBS clarifies biosimilar warning codes

Nicholas O’Donoghue 08/12/2023

Warning codes not always a block on biosimilar substitution, Pharmaceutical Benefits Scheme (PBS) says Pharmacists receiving PBS warning reason codes 162 and 163 when substituting a biosimilar for a reference brand are being urged to ensure they have the correct item code of the dispensed product. In a statement issued by the Department of Health

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Queensland commences shift towards ‘fuller scope of practice’

With less pay...

Erin Threlfall

Transaction fees drive MedAdvisor growth

Yes. Seems like pecuniary interest territory to me. Especially as there is no alternative for Project Stop transactions which we…

james jefferies

Monopolists a threat to small business

Ahh...ok, thanks!

Tod O'Connor

Queensland commences shift towards ‘fuller scope of practice’

How can we call it full scope when pharmacists need additional training!

Dan Abedini

PBS clarifies biosimilar warning codes

Previous Ex netball chief scores Guild role

Next Whale swallows minnow; the Sigma CWH reverse takeover

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous Ex netball chief scores Guild role

Next Whale swallows minnow; the Sigma CWH reverse takeover

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.